Practice Bulletin #86 - Published October 2009 (Reaffirmed 2016)
1. Poorly controlled asthma is associated with prematurity, preeclampsia, growth restriction, and maternal morbidity and mortality.
2. Nonselective β-blockers, carboprost, ergonovine, indomethacin, misoprostol, and dinoprostone can trigger bronchospasm, and they are all commonly used agents in pregnancy/postpartum.
3. Short-acting β2-agonists (e.g. albuterol) are the mainstay for acute asthma exacerbations
4. Long-acting inhaled corticosteroids and inhaled long-acting β2-agonists are the mainstays of maintenance asthma therapy. Oral corticosteroids may be required in the most severe cases.
5. For pregnant patients with poorly-controlled asthma or asthma classified as moderate or severe persistent, fetal growth should be monitored by serial ultrasound beginning around 32 wga.
Show Notes
Wine pairing: 2019 Chardonnay from Sean Minor
Theme music by Evan Handyside
Logo design by JD Dotson (
[email protected])